True Corporation and OYMotion have launched a partnership to develop Neuro AI technology that uses brain-computer interfaces to help patients control prosthetics and rehabilitation devices through neural signals. The innovation aims to improve recovery for stroke and paralysis patients while addressing Thailand's shortage of specialized physical therapists. The technology is currently being piloted at leading Thai hospitals with plans to scale across the public health system if successful.
True Corporation has partnered with OYMotion to develop Neuro AI technology aimed at improving physical therapy and rehabilitation, the company announced Monday.
The collaboration, spearheaded by True's Research and Innovation Center, merges Brain-Computer Interface (BCI) technology with artificial intelligence and a data platform that allows patients to control smart devices or prosthetics using neural signals transmitted over True's network.
The system converts brain activity into commands, stimulating neural pathways to trigger muscle movement. The approach is designed to support cognitive retraining and speed up recovery compared to traditional therapy, especially for stroke patients and those with paralysis or mobility limitations.
True stated the technology is currently being piloted with patients at major Thai hospitals to assess clinical effectiveness. Subject to positive results, it could be rolled out across the public health system.
The initiative also seeks to address the shortage of specialized physical therapists and cut long-term rehabilitation expenses, both significant obstacles to continuous patient care.
According to True, the platform combines OYMotion's neural sensing and signal decoding expertise with its own digital ecosystem, allowing real-time transmission of brainwave and muscle data. This enables robotic devices or prosthetics to perform movements that closely replicate natural human motion.
Ekaraj Panjavinin, head of Research and Innovation at True Corporation, noted the partnership aligns with the company's mission to create technologies that enhance quality of life.
"Merging Thai medical knowledge with world-class NeuroTech will be the foundation for making Thailand's rehabilitation healthcare a leading regional center," he said.
Ni Hualiang, founder and CEO of OYMotion, said the company specializes in affordable rehabilitation solutions using neural sensing and AI-powered signal recognition.
"Our goal is to transform traditional physical therapy into a smarter, more seamless process and establish a new benchmark for rehabilitation," he said.
True indicated the technology could help patients recover faster and gain greater independence, while allowing physicians to customize treatment using brain function data. Hospitals could also broaden rehabilitation service access while upholding care standards.
If adopted widely, the companies believe the initiative could help establish Thailand as a regional NeuroTech innovation hub.